Abstract
Functional sensitization and structural plasticity in the nociceptive pathways and modulatory networks in the peripheral and central nervous system develop following tissue and nerve injury and result in persistent or chronic pain, a major challenge to clinical management. Development of novel analgesic drugs requires a better understanding of the molecular and cellular mechanisms underlying persistent pain. Research during the last three decades has focused on the involvement of neuronal mechanisms in persistent pain. Recently accumulating evidence indicates that reactive glial cells play a critical role in peripheral and central sensitization during the development of persistent pain in variety of animal pain models. The purpose of this review is to highlight important recent advances in astrocytic mechanisms in experimentally persistent pain and the potential to use this information to develop new drugs targeting astrocytic signaling in the treatment of pathological pain.
Keywords: Astrocyte, signal transduction, proinflammatory cytokines, neronal plasticity, pain, analgesic drugs, tissue injury, astrocytic signaling, CNS, peripheral sensitization
Current Signal Transduction Therapy
Title: Astrocytic Signaling in Persistent Pain
Volume: 7 Issue: 1
Author(s): Yu-Xia Chu, Zhi-Qi Zhao and Feng Wei
Affiliation:
Keywords: Astrocyte, signal transduction, proinflammatory cytokines, neronal plasticity, pain, analgesic drugs, tissue injury, astrocytic signaling, CNS, peripheral sensitization
Abstract: Functional sensitization and structural plasticity in the nociceptive pathways and modulatory networks in the peripheral and central nervous system develop following tissue and nerve injury and result in persistent or chronic pain, a major challenge to clinical management. Development of novel analgesic drugs requires a better understanding of the molecular and cellular mechanisms underlying persistent pain. Research during the last three decades has focused on the involvement of neuronal mechanisms in persistent pain. Recently accumulating evidence indicates that reactive glial cells play a critical role in peripheral and central sensitization during the development of persistent pain in variety of animal pain models. The purpose of this review is to highlight important recent advances in astrocytic mechanisms in experimentally persistent pain and the potential to use this information to develop new drugs targeting astrocytic signaling in the treatment of pathological pain.
Export Options
About this article
Cite this article as:
Chu Yu-Xia, Zhao Zhi-Qi and Wei Feng, Astrocytic Signaling in Persistent Pain, Current Signal Transduction Therapy 2012; 7 (1) . https://dx.doi.org/10.2174/157436212799278052
DOI https://dx.doi.org/10.2174/157436212799278052 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MR Imaging of Pancreatic Islets: Tracking Isolation, Transplantation and Function
Current Pharmaceutical Design Editorial [Hot Topic: Adult Stem Cells and Tissue Engineering in Central Nervous System Regenerative Medicine (Guest Editor: Antonio J. Salgado)]
Current Stem Cell Research & Therapy Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents Subtype-Selective Noncompetitive Modulators of Metabotropic Glutamate Receptor Subtype 1 (mGluR1)
Current Topics in Medicinal Chemistry Milk Thistle: A Future Potential Anti-Osteoporotic and Fracture Healing Agent
Current Drug Targets Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders
Current Pharmaceutical Design Recent Patents on Mesenchymal Stem Cell Mediated Therapy in Inflammatory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Emerging and New Treatment Options for Knee Osteoarthritis
Current Rheumatology Reviews Zinc-Permeable Ion Channels: Effects on Intracellular Zinc Dynamics and Potential Physiological/Pathophysiological Significance
Current Medicinal Chemistry Ubiquitin-Proteasome Pathway Components as Therapeutic Targets for CNS Maladies
Current Pharmaceutical Design Substance P and its Inhibition in Ocular Inflammation
Current Drug Targets Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke
Current Drug Targets Development of Medical Images in Differentiating Benign from Malignant Thyroid Nodules
Current Medical Imaging Vascularization of Biomaterials for Bone Tissue Engineering: Current Approaches and Major Challenges
Current Angiogenesis (Discontinued) TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling
Current Neuropharmacology Clinical Potential of Minocycline for Schizophrenia
CNS & Neurological Disorders - Drug Targets Advances in Characterization of Human Sirtuin Isoforms: Chemistries, Targets and Therapeutic Applications
Current Medicinal Chemistry Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease
Current Medicinal Chemistry